Search results
Optimal timing maximizes Paxlovid benefits for treating COVID-19
Medical Xpress· 3 days agoResearchers have described the optimal timing for COVID-19 patients to take the antiviral, Paxlovid, to get the most benefit from the treatment, according to a study published ...
Data: Optimal initiation of Paxlovid in hospitalized COVID patients is 3 to 5 days
Center for Infectious Disease Research and Policy· 3 days agoTaking the SARS-CoV-2 antiviral drug nirmatrelvir-ritonavir (Paxlovid) 3 to 5 days after COVID-19...
'Demoralizing': The data indicates a strong job market but some employment seekers — even those with...
Moneywise via AOL· 6 days agoShe had left her previous job after lining this one up with the pharmaceutical company. Ildefonso...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 2 days agoSales also plummeted 41% to $14.25 billion and missed forecasts for $14.37 billion. Excluding the...
What Factors Will Drive Pfizer's Q1 Performance?
Forbes· 1 day agoWe expect the company to post revenue of $13.8 billion and earnings of $0.50 on a per share and adjusted basis.
Pfizer collab with Austrian research institute leads to new AI models for drug discovery
FierceBiotech· 20 hours agoA three-year collaboration between Pfizer and the Research Center for Molecular Medicine of the...
RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study
FOX 23 News Albany· 3 days agoRALEIGH, N.C. and TEL-AVIV, Israel, April 24, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...
How the search for the origins of COVID-19 turned politically poisonous
Philly.com· 5 days agoThe hunt for the origins of COVID-19 has gone dark in China, the victim of political infighting...
3 Defensive Stocks to Protect Your Portfolio in 2024 | Investing.com NG
Investing.com· 3 days agoAfter the Iran-Israel situation fizzled out for the time being, the Cboe Volatility Index (VIX)...
Pfizer (PFE) Scheduled to Post Quarterly Earnings on Wednesday
ETF DAILY NEWS· 3 days agoPfizer (NYSE:PFE – Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Wednesday, May 1st. Pfizer has set its FY24 guidance at $2.05-2.25 EPS.Parties ...